Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
TLX on Nasdaq
Shares outstanding
334,705,968
Price per share
$7.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
823,173
Total reported value
$7,877,366
% of total 13F portfolios
0%
Share change
+370,707
Value change
+$1,551,679
Number of holders
27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Behrenbruch Christian 7% $404,991,544 23,329,006 Behrenbruch Christian 12 Nov 2024
Kluge Andreas 6.8% $393,638,000 22,675,000 Kluge Andreas 12 Nov 2024

As of 30 Sep 2025, 27 institutional investors reported holding 823,173 shares of Telix Pharmaceuticals Ltd - Ordinary Shares (TLX). This represents 0.25% of the company’s total 334,705,968 outstanding shares.

Institutional Holders of Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,155 $23,631 +$14,575 $7.49 3
2025 Q3 823,173 $7,877,366 +$1,551,679 $9.57 27
2025 Q2 452,466 $7,285,409 +$6,501,020 $16.07 21
2025 Q1 47,647 $798,562 +$736,047 $16.76 6
2024 Q4 3,730 $57,442 +$57,442 $15.40 1